Amanda J. Redig

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Shohei Koyama, Esra A. Akbay, Yvonne Y. Li et al. · Nature Communications · 2016 · 1.6K citations · Full text

Medicine, Immunology, Oncology +17

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study

Daniel Cagney, Allison Martin, Paul J. Catalano et al. · Neuro-Oncology · 2017 · 838 citations · Full text

Medicine, Biostatistics, Oncology +10

Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

Geoffrey R. Oxnard, Yuebi Hu, Kathryn F. Mileham et al. · JAMA Oncology · 2018 · 689 citations · Full text

Medicine, Oncology, Pharmacology +17

Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation

Allison Martin, Daniel Cagney, Paul J. Catalano et al. · JAMA Oncology · 2018 · 307 citations · Full text

Medicine, Oncology, Radiation Oncology +17

KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer

Elsa Krall, Belinda Wang, Diana M. Muñoz et al. · eLife · 2017 · 158 citations · Full text

Medicine, Cancer Biology, Oncology +17